Monitor XWEL's bid price trajectory over the next 180 days — a reverse stock split is the most likely cure if the stock does not organically recover above $1.00. Failure to regain compliance by April 5, 2027, could lead to delisting and a significant loss of liquidity.
Price Chart
Executive Summary
XWELL, Inc. received a Nasdaq deficiency notice on October 7, 2026, for failing to maintain a minimum $1.00 bid price over 30 consecutive business days. The company has a 180-day compliance period until April 5, 2027, to regain compliance, with a potential second 180-day period if eligibility requirements are met. The stock continues trading under XWEL on The Nasdaq Capital Market with no immediate delisting effect.
Key Facts
- Nasdaq notified XWELL on October 7, 2026, of non-compliance with Minimum Bid Price Requirement (Rule 5550(a)(2))
- Closing bid price was below $1.00 for 30 consecutive business days from August 25, 2026 through October 6, 2026
- Initial compliance period is 180 calendar days, expiring April 5, 2027
- To regain compliance, stock must close at $1.00+ for at least 10 consecutive business days during the compliance period
- If stock closes at $0.10 or less for 10 consecutive trading days during compliance period, Nasdaq will issue a Staff Delisting Determination
- Reverse stock split, if used to cure, must be completed no later than 10 business days before April 5, 2027
- Company may be eligible for an additional 180-day compliance period if it meets other initial listing standards
- No immediate effect on listing or trading; stock continues on Nasdaq Capital Market under symbol XWEL
Financial Impact
Delisting risk creates potential for severe liquidity reduction and institutional ownership loss; no specific dollar amounts provided in filing
Risk Factors
- Failure to regain compliance by April 5, 2027, could result in Nasdaq delisting
- Stock price falling to $0.10 or less for 10 consecutive trading days would trigger immediate Staff Delisting Determination
- Reverse stock split, if needed, may face shareholder approval risk and could further pressure the stock
- Delisting would severely reduce institutional ownership and trading liquidity
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-117180 |
| Document: 0001104659-26-117180-index-headers.html | 0001104659-26-117180 |
| Document: 0001104659-26-117180-index.html | 0001104659-26-117180 |
| Document: 0001104659-26-117180.txt | 0001104659-26-117180 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | DEFA14A | $0.7000 | awaiting T+60 | — | $0.7500 (+7.14%) |
Oct 20, 2026 6d ago | 8-K | $0.6530 | awaiting T+60 | — | $0.7500 (−14.85%) |
Oct 7, 2026 19d ago | DEF 14A | $0.9200 | awaiting T+60 | — | $0.7500 (−18.48%) |
Oct 7, 2026 19d ago | 8-K | $0.9200 | awaiting T+60 | — | $0.7500 (−18.48%) |
Aug 5, 2026 11w ago | 8-K | $1.00 | awaiting T+60 | — | $0.7500 (−25.00%) |
Apr 16, 2026 27w ago | EFFECT | $1.04 $0.9399 | ▲ +9.63% | ▲ +16.67% | $0.7500 (+27.88%) |
Apr 1, 2026 29w ago | S-3 | $1.07 $1.04 | ▲ +2.80% | ▲ +16.96% | $0.7500 (+29.91%) |
Apr 1, 2026 29w ago | 8-K | $1.07 $1.04 | ▲ +2.80% | ▲ +16.96% | $0.7500 (+29.91%) |
Apr 1, 2026 29w ago | Press Release | $1.07 $1.04 | ▲ +2.80% | ▲ +16.96% | $0.7500 (+29.91%) |
Feb 25, 2026 34w ago | 8-K | $1.21 $1.46 | ▲ +20.66% | ▲ +13.71% | $0.7500 (−38.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers